Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lapatinib in the Treatment of Ductal Carcinoma in Situ of the Breast

NCT00857714 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT00857714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00857714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lapatinib in the Treatment of Ductal Carcinoma in Situ of the Breast
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2009
Completion date
August 31, 2010
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ductal carcinoma in situ